1 Introduction General anesthesia (GA) is an indispensable life-support modality in modern surgery, and millions of infants and young children worldwide receive GA each year for diagnostic and therapeutic purposes [1]. Sevoflurane, owing to its favorable safety profile, rapid onset, and good tolerability, has become a widely used inhalational general anesthetic in clinical practice [2]. Notably, accumulating evidence has indicated that sevoflurane has potential neurotoxicity.